QIA.XETRA QIAGEN NV

Healthcare Biotechnology XETRA Stock Exchange
45.27 EUR
Close of Nov 6, 2026
27.31 47.16
Market cap
EUR 9.35B
P/E
26.8x
P/B
3.12x
ROE
10.2%
Dividend yield
0.68%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is QIA.XETRA undervalued?

Graham number
Price45.27
Graham value23.50
Premium92.6%

QIA.XETRA trades 92.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

QIAGEN NV fundamental analysis

No fundamental analysis for QIAGEN NV yet.

QIAGEN NV stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About QIAGEN NV

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components fo…

Full company profile